Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ESMCESCALON MEDICAL CORP

OTC · CIK 0000862668
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3845 Electromedical & Electrotherapeutic Apparatus
FY end0630
XBRL facts428

Identity from submissions API

NameESCALON MEDICAL CORP
CIK0000862668
TickersESMC
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3845 Electromedical & Electrotherapeutic Apparatus
EIN330272839
LEI—
Fiscal year end0630
State of incorporationPA PA
Phone6106886830
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
435 DEVON PARK ROAD
SUITE 824
WAYNE
PA
19087
PA
Mailing address
435 DEVON PARK ROAD
SUITE 824
WAYNE
PA
19087
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

466 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001628280-26-074248 000-20127 261562360 34 4969023 1 1
2026-10-13 10-K 10-K 0001628280-26-065683 000-20127 261456846 34 6872223 1 1
2026-09-28 NT 10-K NOTIFICATION OF LATE FILING 0001213900-26-104085 000-20127 261417791 34 25451
2026-05-15 10-Q 10-Q 0001628280-26-035533 000-20127 26986580 34 5441035 1 1
2026-04-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-149790 005-43154 26852218 34 9121
2026-02-17 10-Q 10-Q 0001628280-26-008545 000-20127 26640685 34 5507121 1 1
2026-01-29 8-K CURRENT REPORT 1.01,2.01,9.01 0001213900-26-009497 000-20127 26578135 34 537360 1 1
2025-11-14 10-Q 10-Q 0001628280-25-052330 000-20127 251485526 34 4601636 1 1
2025-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002063350-25-000007 005-43154 251375804 34 6175
2025-09-29 10-K 10-K 0001628280-25-043095 000-20127 251356349 34 6861546 1 1
2025-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002063350-25-000006 005-43154 251110581 34 6232
2025-05-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002063350-25-000005 005-43154 25979680 34 6371
2025-05-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002063350-25-000004 005-43154 25979641 34 6258
2025-05-14 10-Q 10-Q 0000862668-25-000014 000-20127 25945078 34 4786517 1 1
2025-04-04 8-K CURRENT REPORT 4.01,9.01 0001213900-25-028990 000-20127 25813874 34 202219 1 1
2025-02-14 10-Q 10-Q 0000862668-25-000006 000-20127 25627935 34 4386427 1 1
2024-11-14 10-Q 10-Q 0000862668-24-000030 000-20127 241461399 34 3759081 1 1
2024-09-30 10-K 10-K 0000862668-24-000022 000-20127 241339490 34 6310275 1 1
2024-05-14 10-Q 10-Q 0000862668-24-000017 000-20127 24944123 34 4080422 1 1
2024-02-14 10-Q 10-Q 0000862668-24-000008 000-20127 24636018 34 4286451 1 1
2023-11-17 10-Q 10-Q 0000862668-23-000027 000-20127 231418118 34 3871566 1 1
2023-11-15 NT 10-Q NT 10-Q 0001140361-23-053367 000-20127 231409518 34 18077
2023-10-13 10-K 10-K 0000862668-23-000022 000-20127 231324654 34 6462313 1 1
2023-09-29 NT 10-K NT 10-K 0001140361-23-045832 000-20127 231291645 34 16969
2023-05-15 10-Q 10-Q 0000862668-23-000016 000-20127 23923237 34 4640705 1 1
2023-02-14 10-Q 10-Q 0000862668-23-000008 000-20127 23628463 34 4673348 1 1
2022-11-14 10-Q 10-Q 0000862668-22-000026 000-20127 221384805 34 4141276 1 1
2022-11-02 8-K CURRENT REPORT 4.01,9.01 0001213900-22-068665 000-20127 221354282 34 249948 1 1
2022-09-28 10-K 10-K 0000862668-22-000023 000-20127 221276224 34 6789140 1 1
2022-05-13 10-Q 10-Q 0000862668-22-000007 000-20127 22923024 34 4985862 1 1
2022-02-14 10-Q 10-Q 0000862668-22-000004 000-20127 22633288 34 4770287 1 1
2021-11-15 10-Q 10-Q 0000862668-21-000018 000-20127 211410287 34 4111978 1 1
2021-10-22 10-K/A 10-K/A 0000862668-21-000015 000-20127 211339631 34 185525
2021-09-27 10-K 10-K 0000862668-21-000013 000-20127 211282079 34 6881187 1 1
2021-05-14 10-Q 10-Q 0000862668-21-000009 000-20127 21924478 34 4661299 1 1
2021-02-16 10-Q 10-Q 0000862668-21-000004 000-20127 21637662 34 4806066 1 1
2020-11-16 10-Q 10-Q 0000862668-20-000013 000-20127 201315935 34 4208611 1
2020-10-26 10-K/A 10-K/A 0000862668-20-000011 000-20127 201260854 34 274687
2020-09-28 10-K 10-K 0000862668-20-000008 000-20127 201204356 34 6955331 1
2020-05-14 10-Q 10-Q 0000862668-20-000005 000-20127 20877588 34 4914878 1
2020-02-14 10-Q 10-Q 0000862668-20-000002 000-20127 20619270 34 4604230 1
2019-11-14 10-Q 10-Q 0000862668-19-000017 000-20127 191219996 34 3927295 1
2019-10-25 10-K/A 10-K/A 0000862668-19-000014 000-20127 191169849 34 294434
2019-09-27 10-K 10-K 0000862668-19-000010 000-20127 191123048 34 6084145 1
2019-05-14 10-Q 10-Q 0000862668-19-000007 000-20127 19823070 34 3790219 1
2019-02-14 10-Q 10-Q 0000862668-19-000003 000-20127 19605505 34 3606595 1
2018-11-14 10-Q 10-Q 0000862668-18-000025 000-20127 181184608 34 3053561 1
2018-10-26 10-K/A 10-K/A 0000862668-18-000021 000-20127 181142157 34 297393
2018-10-23 SC 13D SC 13D 0001260475-18-000002 005-43154 181134565 34 49295
2018-09-28 10-K 10-K 0000862668-18-000014 000-20127 181094382 34 6197465 1
2018-07-06 8-K 8-K 1.01,1.02,2.03,9.01 0000862668-18-000012 000-20127 18942541 34 6252246
2018-05-14 10-Q 10-Q 0000862668-18-000008 000-20127 18831160 34 3062192 1
2018-02-22 3 PRIMARY DOCUMENT 0001732415-18-000001 4609
2018-02-21 3 PRIMARY DOCUMENT 0001731663-18-000004 4695
2018-02-20 8-K LIVE FILING 5.02 0001299933-18-000178 000-20127 18625472 34 12784
2018-02-16 4 PRIMARY DOCUMENT 0000862668-18-000005 8369
2018-02-15 8-K LIVE FILING 1.01,3.02,5.01,5.03,9.01 0001299933-18-000156 000-20127 18614388 34 115181
2018-02-14 10-Q 10-Q 0000862668-18-000004 000-20127 18614299 34 2705971 1
2018-02-13 SC 13G/A d7811081_13g-a.htm 0000919574-18-001153 005-43154 18603357 34 121991
2018-01-24 8-K LIVE FILING 4.01 0001299933-18-000081 000-20127 18545461 34 16552
2017-11-14 10-Q 10-Q 0000862668-17-000020 000-20127 171201785 34 2205336 1
2017-10-27 10-K/A 10-K/A 0000862668-17-000018 000-20127 171159472 34 300263
2017-09-28 10-K 10-K 0000862668-17-000014 000-20127 171107874 34 5163934 1
2017-07-07 8-K LIVE FILING 5.02 0001299933-17-000689 000-20127 17955194 34 11820
2017-07-06 8-K LIVE FILING 5.07 0001299933-17-000687 000-20127 17951945 34 11618
2017-05-18 DEF 14A DEF 14A 0000862668-17-000012 000-20127 17854589 34 930649
2017-05-18 DEFA14A DEFA14A 0000862668-17-000011 000-20127 17854580 34 420981
2017-05-18 ARS 10-K 0000862668-17-000010 000-20127 17854554 34 1482986
2017-05-15 10-Q 10-Q 0000862668-17-000007 000-20127 17844204 34 2469766 1
2017-02-14 10-Q 10-Q 0000862668-17-000003 000-20127 17608616 34 2424953 1
2017-02-10 SC 13G/A d7412823_13g-a.htm 0000919574-17-001237 005-43154 17594444 34 123435
2017-01-25 25-NSE xslF25X02/primary_doc.xml 0001354457-17-000018 000-20127 34 4315
2017-01-05 8-K LIVE FILING 1.01,2.03,9.01 0001299933-17-000014 000-20127 17510213 34 101261
2016-11-30 SC 13G/A d7350568_sc13g-a1.htm 0000919574-16-016953 005-43154 162025563 34 112284
2016-11-18 10-Q 10-Q 0000862668-16-000052 000-20127 162008149 34 2014821 1
2016-11-16 8-K LIVE FILING 3.01 0001299933-16-003210 000-20127 162002757 34 11134
2016-11-15 NT 10-Q NT 10-Q 0000862668-16-000050 000-20127 161999211 34 33643
2016-11-01 10-K/A 10-K/A 0000862668-16-000047 000-20127 161965214 34 330324
2016-10-12 10-K 10-K 0000862668-16-000043 000-20127 161933489 34 5377932 1
2016-09-29 NT 10-K NT 10-K 0000862668-16-000038 000-20127 161910320 34 33493
2016-09-06 8-K LIVE FILING 3.01 0001299933-16-002938 000-20127 161870838 34 10868
2016-08-22 8-K LIVE FILING 3.01 0001299933-16-002892 000-20127 161843907 34 10636
2016-05-16 10-Q 10-Q 0000862668-16-000036 000-20127 161655210 34 3071194 1
2016-05-16 4 PRIMARY DOCUMENT 0000862668-16-000034 5073
2016-05-16 4 PRIMARY DOCUMENT 0000862668-16-000033 5095
2016-05-16 4 PRIMARY DOCUMENT 0000862668-16-000032 5066
2016-05-16 4 PRIMARY DOCUMENT 0000862668-16-000031 5071
2016-03-07 8-K LIVE FILING 3.01 0001299933-16-002142 000-20127 161487298 34 11002
2016-02-23 8-K LIVE FILING 3.01 0001299933-16-002095 000-20127 161447776 34 10587
2016-02-16 10-Q 10-Q 0000862668-16-000027 000-20127 161428350 34 2871652 1
2016-02-16 SC 13G d7035257_13-g.htm 0000919574-16-010638 005-43154 161422114 34 77268
2016-01-05 8-K LIVE FILING 5.07 0001299933-16-001873 000-20127 161321830 34 10465
2015-11-19 DEF 14A DEF 14A 0000862668-15-000025 000-20127 151243640 34 925121
2015-11-19 DEFA14A DEFA14A 0000862668-15-000024 000-20127 151243630 34 419125
2015-11-19 ARS ARS 0000862668-15-000023 000-20127 151243621 34 1502895
2015-11-16 10-Q 10-Q 0000862668-15-000016 000-20127 151234624 34 2499210 1
2015-11-13 3 PRIMARY DOCUMENT 0001658276-15-000001 3508
2015-10-29 8-K LIVE FILING 5.02 0001299933-15-001568 000-20127 151182997 34 10587
2015-10-28 10-K/A 10-K/A 0000862668-15-000013 000-20127 151181043 34 348139
2015-09-30 8-K LIVE FILING 5.02 0001299933-15-001430 000-20127 151134204 34 10062
2015-09-29 10-K/A 10-K/A 0000862668-15-000011 000-20127 151131146 34 5358899 1
2015-09-28 10-K 10-K 0000862668-15-000009 000-20127 151127828 34 982774
2015-05-14 10-Q 10-Q 0000862668-15-000006 000-20127 15863175 34 4148710 1
2015-02-13 10-Q 10-Q 0000862668-15-000002 000-20127 15614286 34 4291163 1
2014-12-31 8-K LIVE FILING 5.07 0001299933-14-001984 000-20127 141318090 34 10393
2014-11-17 DEFA14A DEFA 14A 0000862668-14-000022 000-20127 141228167 34 2067885
2014-11-14 10-Q 10-Q 0000862668-14-000020 000-20127 141224133 34 3228996 1
2014-11-13 DEF 14A DEF 14A 0000862668-14-000017 000-20127 141218814 34 2066880
2014-11-13 DEFA14A DEFA14A 0000862668-14-000015 000-20127 141218308 34 3347742
2014-11-13 ARS 10-K 0000862668-14-000014 000-20127 141218293 34 1807383
2014-10-28 10-K/A FORM 10-K AMENDMENT NO. 1 0000862668-14-000009 000-20127 141176907 34 462168
2014-09-26 10-K 10-K 0000862668-14-000007 000-20127 141124382 34 8987661 1
2014-05-14 10-Q 10-Q 0000862668-14-000004 000-20127 14839281 34 6585267 1
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000008 5205
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000007 5094
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000006 5177
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000005 5176
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000004 5225
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000003 5234
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000002 5048
2014-05-12 4 PRIMARY DOCUMENT 0001311924-14-000001 5249
2014-02-14 10-Q 10-Q 0000862668-14-000002 000-20127 14616121 34 6595248 1
2014-01-03 8-K LIVE FILING 1.01,5.07 0001299933-14-000011 000-20127 14504699 34 39115
2013-11-14 ARS ARS 0000862668-13-000024 000-20127 131219188 34 1737653
2013-11-14 DEFA14A DEFA14A 0000862668-13-000022 000-20127 131219102 34 341125
2013-11-14 DEF 14A DEF 14A 0000862668-13-000020 000-20127 131219049 34 1093385
2013-11-12 10-Q 10-Q 0000862668-13-000016 000-20127 131208510 34 4952996 1
2013-10-28 10-K/A FORM 10-K AMENDMENT NO. 1 0000862668-13-000014 000-20127 131173262 34 351080
2013-09-25 8-K LIVE FILING 5.02,9.01 0001299933-13-001704 000-20127 131114675 34 21351
2013-09-20 10-K 10-K 0000862668-13-000011 000-20127 131108362 34 13636562 1
2013-07-02 8-K LIVE FILING 5.07 0001299933-13-001221 000-20127 13947371 34 10364
2013-05-24 3 PRIMARY DOCUMENT 0001577865-13-000001 2913
2013-05-22 8-K LIVE FILING 5.02 0001299933-13-000964 000-20127 13864803 34 10986
2013-05-17 DEF 14A NOTICE AND PROXY STATEMENT 0000862668-13-000010 000-20127 13855386 34 976029
2013-05-17 ARS 10-K 0000862668-13-000008 000-20127 13855255 34 1618072
2013-05-17 DEFA14A DEFA14A 0000862668-13-000006 000-20127 13854827 34 426940
2013-05-15 8-K FORM 8-K 5.02 0001193125-13-221465 000-20127 13844644 34 15934
2013-05-10 10-Q 10-Q 0000862668-13-000004 000-20127 13831932 34 7012313 1
2013-02-14 10-Q 10-Q 0000862668-13-000002 000-20127 13608449 34 7038845 1
2012-12-28 8-K LIVE FILING 3.01 0001299933-12-002865 000-20127 121291334 34 11131
2012-12-21 4 PRIMARY DOCUMENT 0001311924-12-000001 4507
2012-11-14 10-Q FORM 10-Q 0000862668-12-000004 000-20127 121205779 34 4921052 1
2012-10-26 10-K/A FORM 10-K AMENDMENT NO. 1 0000862668-12-000002 000-20127 121164457 34 336584
2012-10-18 8-K LIVE FILING 8.01,9.01 0001299933-12-002331 000-20127 121149869 34 39695
2012-10-10 8-K LIVE FILING 1.01,2.01,9.01 0001299933-12-002278 000-20127 121137490 34 235137
2012-09-26 10-K 10-K 0001445305-12-003000 000-20127 121111366 34 9730493 1
2012-08-17 8-K LIVE FILING 3.01 0001299933-12-001947 000-20127 121042985 34 11280
2012-06-29 8-K LIVE FILING 3.01,5.07 0001299933-12-001575 000-20127 12936059 34 12358
2012-05-23 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-12-010012 000-20127 12027464 34 1465
2012-05-17 DEFA14A NOTICE OF INTERNET AVAILABILITY 0001193125-12-238444 000-20127 12852804 34 458269
2012-05-17 DEF 14A NOTICE & PROXY STATEMENT 0001193125-12-238423 000-20127 12852618 34 682313
2012-05-15 10-Q FORM 10-Q 0001193125-12-234917 000-20127 12845813 34 2916420 1
2012-02-22 8-K LIVE FILING 3.01 0001299933-12-000438 000-20127 12630501 34 10601
2012-02-14 10-Q FORM 10-Q 0001193125-12-061211 000-20127 12612048 34 2952147 1
2012-01-23 8-K LIVE FILING 2.06,9.01 0001299933-12-000153 000-20127 12537908 34 40351
2011-11-14 10-Q FORM 10-Q 0001193125-11-311066 000-20127 111203282 34 1872753 1
2011-10-28 10-K/A FORM 10-K AMENDMENT NO. 1 0001193125-11-286289 000-20127 111165577 34 208606
2011-09-28 10-K FORM 10-K 0001193125-11-258876 000-20127 111112624 34 905995
2011-07-07 8-K LIVE FILING 5.07 0001299933-11-002014 000-20127 11955220 34 10084
2011-05-20 DEFA14A FORM DEFA14A 0000950123-11-052434 000-20127 11860899 34 45026
2011-05-20 DEF 14A FORM DEF 14A 0000950123-11-052433 000-20127 11860894 34 360343
2011-05-16 10-Q FORM 10-Q 0000950123-11-050907 000-20127 11848411 34 404219
2011-05-09 UPLOAD filename1.pdf 0000000000-11-028752 46563
2011-05-06 CORRESP filename1.htm 0000950123-11-046678 21547
2011-05-06 8-K LIVE FILING 1.01,9.01 0001299933-11-001381 000-20127 11817902 34 57872
2011-04-26 UPLOAD filename1.pdf 0000000000-11-026013 41955
2011-04-13 CORRESP filename1.htm 0000950123-11-035315 55345
2011-03-23 UPLOAD filename1.pdf 0000000000-11-017924 57785
2011-02-11 10-Q FORM 10-Q 0000950123-11-012864 000-20127 11600168 34 415646
2010-11-15 10-Q FORM 10-Q 0000950123-10-105743 000-20127 101193033 34 311559
2010-10-28 10-K/A FORM 10-K/A 0000950123-10-097439 000-20127 101148345 34 178848
2010-10-12 10-K FORM 10-K 0000950123-10-092815 000-20127 101119922 34 779374
2010-09-29 NT 10-K NT 10-K 0000950123-10-090054 000-20127 101096647 34 24869
2010-09-29 8-K LIVE FILING 2.02,9.01 0001299933-10-003528 000-20127 101094950 34 80359
2010-07-07 8-K LIVE FILING 5.07 0001299933-10-002599 000-20127 10941996 34 10293
2010-06-16 DEF 14A DEF 14A 0000950123-10-058580 000-20127 10900281 34 690777
2010-05-20 10-Q FORM 10-Q 0000950123-10-051593 000-20127 10848247 34 401526
2010-05-18 NT 10-Q FORM NT 10-Q 0000950123-10-050899 000-20127 10843315 34 21351
2010-05-06 8-K LIVE FILING 1.01,2.01,9.01 0001299933-10-001834 000-20127 10808305 34 147650
2010-02-22 10-Q FORM 10-Q 0000950123-10-015235 000-20127 10623512 34 374259
2010-02-17 NT 10-Q/A FORM NT 10-Q/A 0000950123-10-013774 000-20127 10613721 34 21507
2010-02-17 NT 10-Q FORM NT 10-Q 0000950123-10-013688 000-20127 10612576 34 21486
2009-11-18 4 PRIMARY DOCUMENT 0001311924-09-000004 5662
2009-11-18 4 PRIMARY DOCUMENT 0001311924-09-000003 5662
2009-11-18 4 PRIMARY DOCUMENT 0001311924-09-000002 5679
2009-11-18 4 PRIMARY DOCUMENT 0001311924-09-000001 5686
2009-11-16 10-Q 10-Q 0000950123-09-063157 000-20127 091188098 34 280800
2009-10-28 10-K/A 10-K/A 0000950123-09-054122 000-20127 091141706 34 167669
2009-10-13 10-K 10-K 0000950123-09-050042 000-20127 091117538 34 815008
2009-09-29 NT 10-K FORM NT 10-K 0000950123-09-046808 000-20127 091092094 34 23596
2009-06-12 DEF 14A DEF 14A 0000950123-09-013508 000-20127 09888178 34 372894
2009-05-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2009-05-22 09:00:00 9999999995-09-001490 333-157174 09850426 33 2241
2009-05-20 CORRESP filename1.htm 0000893220-09-001255 5775
2009-05-20 CORRESP filename1.htm 0000893220-09-001254 14505
2009-05-19 CORRESP filename1.htm 0000893220-09-001230 5732
2009-05-19 S-3/A FORM S-3/A 0000893220-09-001229 333-157174 09840094 33 151192
2009-05-15 10-Q FORM 10-Q 0000893220-09-001192 000-20127 09833066 34 451005
2009-05-04 UPLOAD filename1.pdf 0000000000-09-023753 41795
2009-04-17 CORRESP filename1.htm 0000893220-09-000844 27011
2009-04-09 UPLOAD filename1.pdf 0000000000-09-018757 63991
2009-03-17 CORRESP filename1.htm 0000893220-09-000588 21836
2009-03-17 CORRESP filename1.htm 0000893220-09-000587 18081
2009-03-03 UPLOAD filename1.pdf 0000000000-09-010994 51561
2009-03-03 UPLOAD filename1.pdf 0000000000-09-010988 59360
2009-02-17 10-Q FORM 10-Q 0000893220-09-000316 000-20127 09614430 34 880014
2009-02-09 S-3 S-3 0000893220-09-000212 333-157174 09578438 33 154165
2009-01-30 CORRESP filename1.htm 0000893220-09-000157 94741
2009-01-16 UPLOAD filename1.pdf 0000000000-09-002852 63007
2009-01-07 8-K LIVE FILING 2.03,5.02,8.01,9.01 0001299933-09-000089 000-20127 09513260 34 30969
2008-12-19 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-049543 021-86266-8L 08070736 34 1880
2008-11-21 8-K LIVE FILING 1.01,3.02,9.01 0001299933-08-005501 000-20127 081208427 34 26594
2008-11-14 10-Q FORM 10-Q 0000893220-08-002988 000-20127 081186334 34 276325
2008-10-28 10-K/A FORM 10-K/A 0000893220-08-002822 000-20127 081145099 34 151432
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053821 5384
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053820 5387
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053819 5433
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053818 5385
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053817 5390
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053815 5624
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053814 5611
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053813 5639
2008-09-29 4 MAIN DOCUMENT DESCRIPTION 0001209191-08-053812 5562
2008-09-29 10-K ESCALON MEDICAL CORP. 0000893220-08-002623 000-20127 081094691 34 1050029
2008-06-05 8-K LIVE FILING 8.01,9.01 0001299933-08-002868 000-20127 08882545 34 25928
2008-05-15 10-Q 10-Q 0000893220-08-001559 000-20127 08835309 34 397139
2008-02-14 10-Q ESCALON MEDICAL CORP. 0000893220-08-000396 000-20127 08617642 34 390487
2007-12-31 3 PRIMARY DOCUMENT 0001311924-07-000013 13629
2007-12-27 8-K LIVE FILING 5.02 0001299933-07-007478 000-20127 071329416 34 23139
2007-12-10 SC 13G/A DOC ONE 0000315066-07-003923 005-43154 071294788 34 8231
2007-12-05 8-K LIVE FILING 5.03,9.01 0001299933-07-007006 000-20127 071287195 34 42598
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000011 5728
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000010 5638
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000009 5702
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000008 5536
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000007 5488
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000006 5489
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000004 5491
2007-12-03 4 PRIMARY DOCUMENT 0001311924-07-000002 5486
2007-11-30 DEF 14A DEFINITIVE PROXY STATEMENT 0000893220-07-003873 000-20127 071278757 34 341049
2007-11-14 10-Q FORM 10-Q 0000893220-07-003729 000-20127 071244544 34 95621
2007-10-31 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0000893220-07-003487 000-20127 071201526 34 68171
2007-10-30 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0000893220-07-003482 000-20127 071199066 34 68171
2007-10-29 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0000893220-07-003473 000-20127 071197394 34 36779
2007-09-28 10-K FORM 10-K ESCALON MEDICAL CORP. 0000893220-07-003221 000-20127 071143051 34 321745
2007-05-15 10-Q FORM 10-Q 0000893220-07-001916 000-20127 07853127 34 111844
2007-03-02 8-K LIVE FILING 1.01,1.02,8.01,9.01 0001299933-07-001302 000-20127 07666990 34 21636
2007-02-14 10-Q FORM 10-Q FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2006 0000893220-07-000361 000-20127 07621020 34 151199
2007-01-18 SC 13G/A escalon123106.txt 0000913414-07-000613 005-43154 07538487 34 25954
2007-01-05 3 PRIMARY DOCUMENT 0001311924-07-000001 10899
2006-12-26 SC 13G/A AMENDED 13G FILING 2006 0000935113-06-000109 005-43154 061299343 34 10070
2006-12-26 SC 13G/A AMENDED 13G FILING 2006 0000935113-06-000101 005-43154 061299310 34 10131
2006-12-26 SC 13G/A AMENDED 13G FILING 2006 0000935113-06-000100 005-43154 061299302 34 10131
2006-11-29 DEF 14A DEFINITIVE PROXY STATEMENT 0000893220-06-002550 000-20127 061245997 34 66180
2006-11-14 10-Q FORM 10-Q ESCALON MEDICAL CORP. 0000893220-06-002452 000-20127 061215026 34 139276
2006-11-13 4 PRIMARY DOCUMENT 0001311924-06-000006 5484
2006-10-27 10KSB/A FORM 10-KSB/A AMENDMENT #1 0000893220-06-002262 000-20127 061169082 34 42332
2006-09-28 10KSB 10KSB FOR ESCALON MEDICAL CORP. 0000893220-06-002109 000-20127 061114087 34 281486
2006-07-14 3 PRIMARY DOCUMENT 0001368931-06-000001 4460
2006-07-06 UPLOAD filename1.pdf 0000000000-06-031401 19773
2006-07-06 8-K LIVE FILING 1.01,4.01,5.02,9.01 0001299933-06-004570 000-20127 06947416 34 23523
2006-06-22 8-K LIVE FILING 4.01,9.01 0001299933-06-004334 000-20127 06920246 34 14467
2006-06-22 8-K/A FORM 8-K/A ESCALON MEDICAL CORP. 9.01 0000893220-06-001435 000-20127 06918314 34 66944
2006-06-06 8-K LIVE FILING 5.02 0001299933-06-003937 000-20127 06887337 34 10330
2006-05-15 10QSB FORM 10-QSB 0000893220-06-001173 000-20127 06841141 34 197748
2006-05-15 CORRESP filename1.txt 0000893220-06-001171 12182
2006-04-11 UPLOAD filename1.txt 0000000000-06-017040 4708
2006-03-21 CORRESP filename1.txt 0000893220-06-000639 2854
2006-03-21 CORRESP filename1.txt 0000893220-06-000638 37360
2006-03-09 3 PRIMARY DOCUMENT 0001311924-06-000002 4786
2006-03-07 UPLOAD filename1.txt 0000000000-06-011332 11521
2006-02-28 8-K LIVE FILING 5.02 0001299933-06-001329 000-20127 06649412 34 11139
2006-02-14 10QSB FORM 10-QSB FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2005 0000893220-06-000272 000-20127 06607254 34 201512
2006-01-26 SC 13G escalonmedcorp123105.txt 0000913414-06-000852 005-43154 06551102 34 22111
2005-11-14 10QSB FORM 10QSB FOR ESCALON MEDICAL CORP. 0000893220-05-002655 000-20127 051201701 34 178289
2005-11-01 4 PRIMARY DOCUMENT 0001311924-05-000009 5531
2005-11-01 3 PRIMARY DOCUMENT 0001311924-05-000008 4144
2005-10-28 DEF 14A ESCALON MEDICAL CORP. DEFINITIVE PROXY STATEMENT 0000893220-05-002410 000-20127 051162366 34 85669
2005-10-13 4 PRIMARY DOCUMENT 0001311924-05-000007 7179
2005-10-07 10-K FORM 10-K FOR THE FISCAL YEAR ENDED JUNE 30, 2005 0000893220-05-002253 000-20127 051128374 34 274397
2005-09-29 NT 10-K NT 10-K FOR ESCALON MEDICAL CORP. 0000893220-05-002229 000-20127 051111819 34 7927
2005-09-29 8-K LIVE FILING 2.02,9.01 0001299933-05-004957 000-20127 051109892 34 74908
2005-08-22 4 PRIMARY DOCUMENT 0001311924-05-000006 5644
2005-08-22 4 PRIMARY DOCUMENT 0001311924-05-000005 5482
2005-08-22 4 PRIMARY DOCUMENT 0001311924-05-000004 5485
2005-08-22 4 PRIMARY DOCUMENT 0001311924-05-000003 5646
2005-08-22 4 PRIMARY DOCUMENT 0001311924-05-000002 5478
2005-08-22 4 PRIMARY DOCUMENT 0001311924-05-000001 5480
2005-07-28 3 MAIN DOCUMENT DESCRIPTION 0001209191-05-039125 3491
2005-07-15 8-K LIVE FILING 1.01,5.02,9.01 0001299933-05-003485 000-20127 05956607 34 20886
2005-06-29 8-K LIVE FILING 1.01,9.01 0001299933-05-003188 000-20127 05925555 34 40159
2005-05-24 8-K LIVE FILING 8.01 0001299933-05-002531 000-20127 05853882 34 20660
2005-05-16 10-Q FORM 10-Q FOR ESCALON MEDICAL CORP. 0000893220-05-001217 000-20127 05834540 34 190651
2005-04-07 8-K LIVE FILING 1.02 0001299933-05-001631 000-20127 05739703 34 26195
2005-02-14 10-Q FORM 10-Q ESCALON MEDICAL CORP. 0000893220-05-000335 000-20127 05612996 34 199405
2005-02-14 SC 13G DOC ONE 0000315066-05-000689 005-43154 05602107 34 9219
2005-01-06 8-K LIVE FILING 4.01,9.01 0001299933-05-000080 000-20127 05514742 34 18746
2005-01-03 8-K LIVE FILING 5.02,9.01 0001299933-05-000018 000-20127 05503236 34 14275
2004-12-08 4 MAIN DOCUMENT DESCRIPTION 0001209191-04-056548 8094
2004-12-07 8-K LIVE FILING 1.01 0001299933-04-002123 000-20127 041188369 34 23986
2004-11-22 10-Q FORM 10-Q FOR ESCALON MEDICAL CORP 0000893220-04-002545 000-20127 041161578 34 607310
2004-11-16 NT 10-Q FORM 12B-25 ESCALON MEDICAL CORP. 0000893220-04-002500 000-20127 041148145 34 7943
2004-10-27 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-04-042076 000-20127 04047858 34 1856
2004-10-27 DEFR14A DEFR 14A ESCALON MEDICAL CORP. 0000893220-04-002261 000-20127 041097738 34 138774
2004-10-26 DEF 14A DEF 14A ESCALON MEDICAL CORP. 0000893220-04-002256 000-20127 041096796 34 138809
2004-10-06 8-K/A FORM 8-K/A ESCALON MEDICAL CORP. 2.01,9.01 0000893220-04-002085 000-20127 041068635 34 91924
2004-09-28 10-K FORM 10-K ESCALON MEDICAL CORP. 0000893220-04-002033 000-20127 041049803 245657
2004-09-24 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-002018 8932
2004-09-10 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001933 10339
2004-08-10 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001662 10353
2004-08-04 8-K FORM 8-K ESCALON MEDICAL CORP. 2,7 0000893220-04-001577 000-20127 04951662 6296
2004-07-26 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001469 10331
2004-07-12 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001378 10949
2004-07-02 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001343 246967
2004-06-30 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001321 10225
2004-05-17 CB/A FORM CB/A DREW SCIENTIFIC GROUP PLC 0000893220-04-001074 563903
2004-05-17 10-Q FORM 10-Q FOR PERIOD ENDED MARCH 31, 2004 0000893220-04-001056 000-20127 04810227 213281
2004-04-21 424B3 424B3 ESCALON MEDICAL CORP 0000893220-04-000732 333-114332 04744410 50999
2004-04-21 8-K FORM 8-K FOR ESCALON MEDICAL CORP. 5,7 0000893220-04-000722 000-20127 04743664 11767
2004-04-08 S-3 FORM S-3 ESCALON MEDICAL CORP. 0000893220-04-000642 333-114332 04725378 330367
2004-04-08 CB FORM CB 0000893220-04-000640 47963
2004-04-08 8-K FORM 8-K FOR ESCALON MEDICAL CORP DATED 4/8/04 5,7 0000893220-04-000633 000-20127 04723980 11073
2004-03-30 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-014734 021-86266-8L 04021478 1822
2004-03-18 8-K FORM 8-K DATED MARCH 17, 2004 5,7 0000893220-04-000489 000-20127 04678000 9888
2004-03-08 4 PRIMARY DOCUMENT 0001260475-04-000031 8596
2004-03-08 4 PRIMARY DOCUMENT 0001260475-04-000030 8396
2004-03-08 4 PRIMARY DOCUMENT 0001260475-04-000029 13494
2004-03-08 4 PRIMARY DOCUMENT 0001260475-04-000028 8424
2004-03-04 4 PRIMARY DOCUMENT 0001260475-04-000027 19991
2004-03-04 4 PRIMARY DOCUMENT 0001260475-04-000026 13487
2004-03-04 4 PRIMARY DOCUMENT 0001260475-04-000025 23925
2004-03-03 4 PRIMARY DOCUMENT 0001260475-04-000024 8594
2004-03-03 4 PRIMARY DOCUMENT 0001260475-04-000023 13769
2004-03-01 4/A PRIMARY DOCUMENT 0001260475-04-000022 13550
2004-03-01 4/A PRIMARY DOCUMENT 0001260475-04-000021 9962
2004-03-01 4 PRIMARY DOCUMENT 0001260475-04-000017 8598
2004-02-27 4 PRIMARY DOCUMENT 0001260475-04-000016 8594
2004-02-27 4 PRIMARY DOCUMENT 0001260475-04-000015 8424
2004-02-27 4 PRIMARY DOCUMENT 0001260475-04-000014 8420
2004-02-27 4 PRIMARY DOCUMENT 0001260475-04-000013 8424
2004-02-25 4 PRIMARY DOCUMENT 0001260475-04-000012 13487
2004-02-25 4 PRIMARY DOCUMENT 0001260475-04-000011 8420
2004-02-25 4 PRIMARY DOCUMENT 0001260475-04-000010 13489
2004-02-25 4 PRIMARY DOCUMENT 0001260475-04-000009 13483
2004-02-25 4 PRIMARY DOCUMENT 0001260475-04-000008 13765
2004-02-24 4 PRIMARY DOCUMENT 0001260475-04-000007 8594
2004-02-24 4 PRIMARY DOCUMENT 0001260475-04-000006 8424
2004-02-24 4 PRIMARY DOCUMENT 0001260475-04-000005 8422
2004-02-24 4 PRIMARY DOCUMENT 0001260475-04-000004 8416
2004-02-20 4 PRIMARY DOCUMENT 0001260475-04-000003 8590
2004-02-20 4 PRIMARY DOCUMENT 0001260475-04-000002 8422
2004-02-20 4 PRIMARY DOCUMENT 0001260475-04-000001 8406
2004-02-11 10-Q FORM 10-Q FOR THE QUARTER ENDED DECEMBER 31, 2003 0000893220-04-000165 000-20127 04583820 162878
2004-02-03 SC 13G/A SCHEDULE 13G FOR DECEMBER, 2003 0001095449-04-000016 005-43154 04560577 8573
2003-12-23 4/A PRIMARY DOCUMENT 0001260475-03-000017 6454
2003-12-23 4 PRIMARY DOCUMENT 0001260475-03-000016 6383
2003-12-23 4 PRIMARY DOCUMENT 0001260475-03-000015 7759
2003-12-04 4 PRIMARY DOCUMENT 0001260475-03-000013 6348
2003-11-26 4/A PRIMARY DOCUMENT 0001260475-03-000012 6419
2003-11-26 4 PRIMARY DOCUMENT 0001260475-03-000011 6348
2003-11-19 4/A PRIMARY DOCUMENT 0001260475-03-000009 4512
2003-11-19 4 PRIMARY DOCUMENT 0001260475-03-000008 6360
2003-11-19 4/A PRIMARY DOCUMENT 0001260475-03-000007 4512
2003-11-13 4 PRIMARY DOCUMENT 0001260475-03-000006 4395
2003-11-13 4 PRIMARY DOCUMENT 0001260475-03-000004 4440
2003-11-13 4 PRIMARY DOCUMENT 0001260475-03-000003 4387
2003-11-13 4 PRIMARY DOCUMENT 0001260475-03-000002 4393
2003-11-13 4 PRIMARY DOCUMENT 0001260475-03-000001 4439
2003-11-13 4 PRIMARY DOCUMENT 0001260472-03-000002 4391
2003-11-13 4 PRIMARY DOCUMENT 0001260473-03-000001 4395
2003-11-10 10-Q FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2003 0000893220-03-001847 000-20127 03988678 106581
2003-10-10 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-03-038503 000-20127 03034960 1827
2003-10-09 DEF 14A DEF 14A ESCALON MEDICAL CORP. 0000893220-03-001646 000-20127 03934649 72737
2003-09-29 10-K ESCALON MEDICAL CORP. FORM 10-K DATED 6/30/03 0000893220-03-001604 000-20127 03913551 220891
2003-09-26 8-K ESCALON MEDICAL CORP. FORM 8-K DATED 9/26/03 12,7 0000893220-03-001598 000-20127 03911186 17976
2003-08-25 3 PRIMARY DOCUMENT 0001260474-03-000001 3871
2003-05-15 10-Q FORM 10-Q ESCALON MEDICAL GROUP 0000893220-03-000931 000-20127 03700765 135460
2003-05-13 8-K FORM 8-K DATE OF REPORT: MAY 12, 2003 7,9 0000893220-03-000889 000-20127 03694245 17545
2003-04-11 10-K/A FORM 10-K/A ESCALON MEDICAL CORP 0000893220-03-000608 000-20127 03647456 237470
2003-04-11 10-Q/A FORM 10-Q/A ESCALON MEDICAL CORP. 0000893220-03-000607 000-20127 03647452 122139
2003-03-04 10-Q/A FORM 10-Q/A FOR ESCALON MEDICAL CORP. 0000893220-03-000240 000-20127 03590302 106356
2003-03-04 10-K/A FORM 10-K/A ESCALON MEDICAL CORP 0000893220-03-000239 000-20127 03590301 410823
2003-02-14 10-Q FORM 10-Q FOR THE QUARTER ENDED DECEMBER 31, 2002 0000893220-03-000151 000-20127 03566429 147379
2003-02-14 SC 13G SCHEDULE 13G FOR DECEMBER 2002 0001095449-03-000026 005-43154 03564931 9094
2003-02-14 SC 13D SCHEDULE 13D FOR JULY 2002 0001095449-03-000025 005-43154 03564928 9064
2003-02-14 SC 13D SCHEDULE 13D FOR AUGUST 2002 0001095449-03-000024 005-43154 03564923 9066
2002-11-14 10-Q FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2002 0000893220-02-001360 000-20127 02821990 102716
2002-10-24 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-02-055804 000-20127 02063000 1827
2002-10-01 DEF 14A DEFINITIVE PROXY STATEMENT DATED 11/1/2002 0000893220-02-001159 000-20127 02777854 72690
2002-09-26 10-K FORM 10-K ESCALON MEDICAL CORP. 0000893220-02-001153 000-20127 02772947 186334
2002-05-14 10-Q FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2002 0000893220-02-000631 000-20127 02644978 79687
2002-02-26 S-8 FORM S-8 FOR ESCALON MEDICAL CORP. 0000893220-02-000186 333-83392 02558432 16724
2002-02-14 10-Q FORM 10-Q - ESCALON MEDICAL CORP. 0000893220-02-000148 000-20127 02549003 77831
2002-02-08 10-Q/A FORM 10-Q/A - ESCALON MEDICAL CORP. 0000893220-02-000106 000-20127 02531884 37448
2002-02-08 8-K FORM 8-K - ESCALON MEDICAL CORP. 5 0000893220-02-000105 000-20127 02531879 5862
2001-11-14 10-Q FORM 10-Q FOR THE QUARTERLY PERIOD ENDED 09/30/01 0000893220-01-500900 000-20127 1791188 93473
2001-11-13 8-K ESCALON MEDICAL CORP FORM 8-K DATED 11/7/2001 5,7 0000893220-01-500874 000-20127 1785206 9377
2001-10-01 DEF 14A DEFINITIVE PROXY STATEMENT FOR 11/02/2001 0000893220-01-500727 000-20127 1749329 237964
2001-09-28 10-K ANNUAL REPORT FOR FISCAL YEARD ENDED JUNE 30,2001 0000893220-01-500721 000-20127 1748444 274648
2001-09-21 PRE 14A PRELIMINARY PROXY STATEMENT 0000893220-01-500708 000-20127 1742313 270729
2001-09-06 424B3 ESCALON MEDICAL CORPORATION PROSPECTUS 0000893220-01-500678 333-68144 1732544 38071

Latest XBRL company facts

One latest value per concept from companyfacts (428 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 7.42M 2026-11-13 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
dei EntityPublicFloat Entity Public Float USD 505,622 2025-12-31 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.22M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AccountsPayableInterestBearingInterestRate Accounts Payable, Interest-bearing, Interest Rate pure 0.013 2016-03-31 2016 Q3 10-Q 2016-05-16 0000862668-16-000036
us-gaap AccountsReceivableGross Accounts Receivable, before Allowance for Credit Loss USD 1.99M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 2.13M 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.91M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AccountsReceivableNetNoncurrent Accounts Receivable, after Allowance for Credit Loss, Noncurrent USD 68,707 2012-06-30 2012 FY 10-K 2012-09-26 0001445305-12-003000
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 797,938 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AccruedRentCurrentAndNoncurrent Accrued Rent USD 0 2020-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 967,313 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 69.70M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 52,293 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap AdvertisingExpense Advertising Expense USD 4,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 74,161 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AllowanceForDoubtfulAccountsReceivableChargeOffs Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) USD -63,094 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 28,641 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap Assets Assets USD 10.07M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AssetsCurrent Assets, Current USD 7.70M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap AssetsDisposedOfByMethodOtherThanSaleInPeriodOfDispositionGainLossOnDisposition1 Assets Disposed of by Method Other than Sale, in Period of Disposition, Gain (Loss) on Disposition USD -87,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-09-26 0001445305-12-003000
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Assets of Disposal Group, Including Discontinued Operation, Noncurrent (Deprecated 2014-01-31) USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap Cash Cash USD 540,908 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.67M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 329,884 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 3.67M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -343,374 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 602,290 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 0 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-14 0000862668-14-000004
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 2.46M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 35.00M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 7.42M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 7.42M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,415 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -381,883 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 129,000 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 212,555 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 159,000 2023-07-01 2023-09-30 2024 Q1 10-Q 2023-11-17 0000862668-23-000027
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 4.30M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap ConvertiblePreferredDividendsNetOfTax Convertible Preferred Dividends, Net of Tax USD 51,600 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 2.15 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 2.08M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 3.88M 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap CostsAndExpenses Costs and Expenses USD 3.44M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 4,037 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap CustomerDepositsCurrent Customer Deposits, Current USD 61,494 2018-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 4.37M 2012-10-18 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio pure 2.15 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.01 2020-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 731 2022-07-01 2022-12-31 2023 Q2 10-Q 2023-02-14 0000862668-23-000008
us-gaap DeferredCompensationArrangementWithIndividualDistributionPaid Deferred Compensation Arrangement with Individual, Distribution Paid USD 101,891 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap DeferredCompensationArrangementWithIndividualDistributionsPaid Deferred Compensation Arrangement with Individual, Distributions Paid (Deprecated 2017-01-31) USD 101,891 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 625,619 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 1.14M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -1.14M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.14M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 188,777 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredRevenue Deferred Revenue USD 505,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 437,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 504,629 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 320,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -84,833 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 42,456 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 6.72M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 1.14M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.33M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6.36M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsRegulatoryAssetsAndLiabilities Deferred Tax Assets, Regulatory Assets and Liabilities USD 184,987 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 0 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits USD 56,851 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits USD 0 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 16,560 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 48,515 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves USD 7,175 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 5.39M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 186,958 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1,819 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate pure 0.045 2020-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 101,228 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 51,528 2024-07-01 2025-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax Discontinued Operation, Amount of Other Income (Loss) from Disposition of Discontinued Operation, Net of Tax (Deprecated 2015-01-31) USD 49,000 2015-01-01 2015-03-31 2015 Q3 10-Q 2015-05-14 0000862668-15-000006
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-16 0000862668-16-000036
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD -217,983 2018-10-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayable Disposal Group, Including Discontinued Operation, Accounts Payable USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities USD 91,000 2016-03-31 2016 Q3 10-Q 2016-05-16 0000862668-16-000036
us-gaap DisposalGroupIncludingDiscontinuedOperationGoodwill Disposal Group, Including Discontinued Operation, Goodwill (Deprecated 2014-01-31) USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap DisposalGroupIncludingDiscontinuedOperationGoodwill1 Disposal Group, Including Discontinued Operation, Goodwill USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssets Disposal Group, Including Discontinued Operation, Intangible Assets USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet Disposal Group, Including Discontinued Operation, Intangible Assets, Net (Deprecated 2014-01-31) USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap DisposalGroupIncludingDiscontinuedOperationInventory Disposal Group, Including Discontinued Operation, Inventory (Deprecated 2014-01-31) USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap DisposalGroupIncludingDiscontinuedOperationLongLivedAssetsNoncurrent Disposal Group, Including Discontinued Operation, Long Lived Assets, Noncurrent (Deprecated 2015-01-31) USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Current USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Current USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet Disposal Group, Including Discontinued Operation, Property, Plant, and Equipment, Net (Deprecated 2014-01-31) USD 0 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap Dividends Dividends USD 13,005 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0000862668-18-000025
us-gaap DividendsPayableAmountPerShare Dividends Payable, Amount Per Share USD/shares 0.223 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 6,503 2018-01-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 112,389 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.02 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.1 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.02 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.397 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.611 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.344 2024-07-01 2025-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.003 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.005 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.003 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.004 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 0 2013-07-01 2013-09-30 2014 Q1 10-Q 2013-11-12 0000862668-13-000016
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 0 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 667,268 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2017-09-30 2018 Q1 10-Q 2017-11-14 0000862668-17-000020
us-gaap EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) USD 4.71M 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.367 2022-03-31 2022 Q3 10-Q 2022-05-13 0000862668-22-000007
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 2,728 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 211,215 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 350,142 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 343,242 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap FinancingReceivableAllowanceForCreditLossesRecovery Financing Receivable, Allowance for Credit Loss, Recovery USD 0 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 0 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1,000 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 8,045 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 149,835 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD 758,000 2021-07-01 2022-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 2.81M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 63,589 2012-07-01 2012-09-30 2013 Q1 10-Q 2012-11-14 0000862668-12-000004
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 1.88M 2013-01-01 2013-03-31 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD -86,885 2011-07-01 2012-03-31 2012 Q3 10-Q 2012-05-15 0001193125-12-234917
us-gaap Goodwill Goodwill USD 0 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2021-07-01 2022-06-30 2022 Q3 10-Q 2022-05-13 0000862668-22-000007
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD 269,243 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 113,000 2014-01-01 2014-03-31 2014 Q3 10-Q 2014-05-14 0000862668-14-000004
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 2.87M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 2.87M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 113,000 2014-01-01 2014-03-31 2014 Q3 10-Q 2014-05-14 0000862668-14-000004
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.04 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.15 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2016-01-01 2016-03-31 2016 Q3 10-Q 2016-05-16 0000862668-16-000036
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares -0.04 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap IncomeTaxesPaid Income Taxes Paid USD 15,778 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 5,728 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -1.76M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Amount USD 8,189 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 603,367 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -14,295 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 7,065 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 11,785 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 290,771 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 32,097 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -458,630 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 8,840 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -19,591 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 17,106 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0000862668-18-000025
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 116,332 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD -112,389 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 101,505 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInNotesReceivableRelatedParties Increase (Decrease) in Notes Receivable, Related Parties USD 100,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-05-15 0001628280-26-035533
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -36,187 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -24,754 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInOtherDeferredLiability Increase (Decrease) in Other Deferred Liability USD -484 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -13,716 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -21,757 2024-07-01 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -203,194 2024-07-01 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap IncreaseDecreaseInPensionAndPostretirementObligations Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits USD 0 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 6.77M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 605,006 2020-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 168,500 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap IndefiniteLivedTradeNames Indefinite-Lived Trade Names USD 605,006 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap InterestExpense Interest Expense USD 20,785 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000862668-24-000022
us-gaap InterestExpenseDebt Interest Expense, Debt USD 14,710 2024-07-01 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 305 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 42,242 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1,310 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 0 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap InventoriesPropertyHeldForSaleCurrent Disposal Group, Including Discontinued Operation, Inventory, Current (Deprecated 2015-01-31) USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 676,912 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 730,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap InventoryGross Inventory, Gross USD 1.73M 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap InventoryNet Inventory, Net USD 1.84M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 997,520 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap InventoryRawMaterialsAndSuppliesNetOfReserves Inventory, Raw Materials and Supplies, Net of Reserves USD 652,613 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 982,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 217,000 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 59,552 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 123,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap InventoryWriteDown Inventory Write-down USD -150,000 2022-07-01 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2,128 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 346,302 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 28,549 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap LegalFees Legal Fees USD 5,000 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-16 0000862668-16-000036
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.40M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 211,029 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 223,112 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 224,496 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 226,425 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 221,947 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 289,918 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 155,350 2021-12-31 2022 Q2 10-Q 2022-02-14 0000862668-22-000004
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 278,225 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 1,200 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 1,200 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 600 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap Liabilities Liabilities USD 3.87M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 10.07M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.83M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 401,863 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 96,000 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 90,770 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap LiabilitiesOtherThanLongtermDebtNoncurrent Liabilities, Other than Long-term Debt, Noncurrent USD 44,736 2020-09-30 2021 Q1 10-Q 2020-11-16 0000862668-20-000013
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 634,301 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 852,000 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap LineOfCreditFacilityFairValueOfAmountOutstanding Line of Credit Facility, Fair Value of Amount Outstanding USD 201,575 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.082 2023-03-31 2023 Q3 10-Q 2023-05-15 0000862668-23-000016
us-gaap LineOfCreditFacilityPeriodicPaymentInterest Line of Credit Facility, Periodic Payment, Interest USD 11,000 2022-07-01 2023-03-31 2023 Q3 10-Q 2023-05-15 0000862668-23-000016
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2023-03-31 2023 Q3 10-Q 2023-05-15 0000862668-23-000016
us-gaap LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease Loans and Leases Receivable, Related Parties, Period Increase (Decrease) USD 100,000 2025-07-01 2025-12-31 2026 Q2 10-Q 2026-02-17 0001628280-26-008545
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 4.00M 2012-05-11 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 18,853 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.01 2022-03-31 2022 Q3 10-Q 2022-05-13 0000862668-22-000007
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 717,460 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap MultiemployerPlansPlanContributions1 Multiemployer Plans, Plan Contributions (Deprecated 2020-01-31) USD 0 2017-07-01 2018-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -883 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 35,288 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -22,117 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 603,173 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -472,689 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 269,243 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 446,647 2024-07-01 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 135,530 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 256,378 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD 135,530 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.83M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap NotesAndLoansPayableCurrent Notes and Loans Payable, Current USD 3,094 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap NotesAssumed1 Notes Assumed USD 1.14M 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-11-14 0000862668-19-000017
us-gaap NotesPayable Notes Payable USD 168,313 2023-03-31 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 0 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 0 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap NotesPayableToBankCurrent Notes Payable to Bank, Current USD 0 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 2 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 10.80M 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 269,548 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingLeaseCost Operating Lease, Cost USD 5,463 2025-10-23 2026 Q2 10-Q 2026-02-17 0001628280-26-008545
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 77,003 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.12M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 216,743 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 901,959 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.09M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 997,739 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 356,414 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 189,790 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears Operating Leases, Future Minimum Payments, Due in Four and Five Years USD 547,788 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 188,755 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 256,311 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears Operating Leases, Future Minimum Payments, Due in Two and Three Years USD 484,428 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 272,881 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 2,728 2021-03-31 2021 Q3 10-Q 2021-05-14 0000862668-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year USD 321,612 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 95,418 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.089 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 76,231 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap OtherAssetsCurrent Other Assets, Current USD 284,501 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 68,998 2011-09-30 2012 Q1 10-Q 2011-11-14 0001193125-11-311066
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 319,060 2011-07-01 2012-03-31 2012 Q3 10-Q 2012-05-15 0001193125-12-234917
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD 0 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 515,622 2012-07-01 2013-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax USD 0 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment Realized upon Sale or Liquidation, before Tax (Deprecated 2013-01-31) USD 578,436 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-20 0000862668-13-000011
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 0 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-14 0000862668-14-000004
us-gaap OtherIncome Other Income USD 758,000 2019-07-01 2020-06-30 2021 Q3 10-Q 2021-05-14 0000862668-21-000009
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 166,262 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 89,303 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap OtherLongTermDebt Other Long-term Debt USD 82,000 2022-12-31 2023 Q2 10-Q 2023-02-14 0000862668-23-000008
us-gaap OtherLongTermNotesPayable Other Notes Payable, Noncurrent USD 0 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 5,000 2024-07-01 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2.81M 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-15 0001628280-26-035533
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 40,184 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 51,838 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 0 2011-07-01 2012-03-31 2012 Q3 10-Q 2012-05-15 0001193125-12-234917
us-gaap OtherShortTermBorrowings Other Short-term Borrowings USD 41,000 2022-12-31 2023 Q2 10-Q 2023-02-14 0000862668-23-000008
us-gaap PaymentsForLeasingCosts Payments for Leasing Costs USD 73,754 2020-07-01 2020-09-30 2021 Q1 10-Q 2020-11-16 0000862668-20-000013
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-30 0000862668-24-000022
us-gaap PaymentsToAcquireInterestInSubsidiariesAndAffiliates Payments to Acquire Interest in Subsidiaries and Affiliates USD 0 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-28 0000862668-22-000023
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent Liability, Retirement and Postemployment Benefits USD 792,000 2021-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap PensionAndOtherPostretirementBenefitContributions Payment for Pension and Other Postretirement Benefits USD 8,491 2013-01-01 2019-10-03 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities Liability, Defined Benefit Plan, Current USD 0 2020-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent Liability, Defined Benefit Plan USD 901,238 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent Liability, Defined Benefit Plan, Noncurrent USD 0 2020-06-30 2020 FY 10-K 2020-09-28 0000862668-20-000008
us-gaap PreferredStockAmountOfPreferredDividendsInArrears Preferred Stock, Amount of Preferred Dividends in Arrears USD 444,996 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 12,865 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 12,865 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 2.00M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 2.00M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 2.00M 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 645,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 1.10M 2008-11-19 2008-11-20 2014 FY 10-K 2015-09-29 0000862668-15-000011
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 0 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-27 0000862668-21-000013
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -426 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD -85,000 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 2.98M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 500,000 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 6.17M 2013-01-01 2013-03-31 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 36,575 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2017-07-01 2017-09-30 2018 Q1 10-Q 2017-11-14 0000862668-17-000020
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 32,078 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.15M 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 150,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-09-26 0001445305-12-003000
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 993,918 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 23,694 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 126 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap ProvisionForLeaseLosses Provision for Lease Losses USD 155,000 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap ProvisionForLoanLeaseAndOtherLosses Provision for Loan, Lease, and Other Losses USD 126 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RelatedPartyDepositLiabilities Related Party Deposit Liabilities USD 100,000 2025-12-31 2026 Q2 10-Q 2026-02-17 0001628280-26-008545
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 645,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 645,000 2018-02-14 2023 Q2 10-Q 2023-02-14 0000862668-23-000008
us-gaap RelatedPartyTransactionDueFromToRelatedPartyCurrent Related Party Transaction, Due from (to) Related Party, Current USD 645,000 2017-12-31 2018 Q2 10-Q 2018-02-14 0000862668-18-000004
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 10,000 2014-07-01 2015-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 32,033 2014-07-01 2015-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate Rate 0.14 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-05-15 0001628280-26-035533
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 201,575 2018-07-01 2018-12-31 2020 Q2 10-Q 2020-02-14 0000862668-20-000002
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 883 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 60,000 2017-07-01 2017-12-31 2019 Q2 10-Q 2019-02-14 0000862668-19-000003
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 94,398 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RestrictedCash Restricted Cash USD 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 250,000 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -64.16M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 9.48M 2024-07-01 2025-03-31 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 3.71M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap Revenues Revenues USD 2.94M 2023-07-01 2023-09-30 2025 Q1 10-Q 2024-11-14 0000862668-24-000030
us-gaap SaleAndLeasebackTransactionGainLossNet Sale and Leaseback Transaction, Gain (Loss), Net USD 1,092 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap SalesAndExciseTaxPayableCurrentAndNoncurrent Sales and Excise Tax Payable USD 41,952 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 6.65M 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 7.35M 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 692,679 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0000862668-19-000007
us-gaap SalesTypeLeaseInterestIncome Sales-type Lease, Interest Income USD 1,005 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap SalesTypeLeaseNetInvestmentInLease Sales-type Lease, Net Investment in Lease USD 26,312 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap SalesTypeLeaseNetInvestmentInLeaseBeforeAllowanceForCreditLossCurrent SalesTypeLeaseNetInvestmentInLeaseBeforeAllowanceForCreditLossCurrent USD 4,621 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap SalesTypeLeaseNetInvestmentInLeaseBeforeAllowanceForCreditLossNoncurrent SalesTypeLeaseNetInvestmentInLeaseBeforeAllowanceForCreditLossNoncurrent USD 24,849 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap SecuredDebtCurrent Secured Debt, Current USD 3,531 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 142,508 2024-06-30 2025 Q3 10-Q 2025-05-14 0000862668-25-000014
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 1.27M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 0 2019-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 21,000 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.79 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 136,000 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 21,000 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.79 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.57 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-29 0001628280-25-043095
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 367,500 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap SharesIssued Shares, Issued shares 25,000 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap ShortTermBorrowings Short-term Debt USD 0 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 66,000 2025-07-01 2025-09-30 2026 Q1 10-Q 2025-11-14 0001628280-25-052330
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 73,401 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 150,000 2014-07-01 2015-06-30 2014 FY 10-K 2015-09-29 0000862668-15-000011
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 6.20M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 25,000 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 645,000 2017-07-01 2018-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 645,000 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0000862668-18-000008
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 19,750 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0000862668-17-000014
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 25 2015-07-01 2016-06-30 2016 FY 10-K 2016-10-12 0000862668-16-000043
us-gaap TreasuryStockRetiredParValueMethodAmount Treasury Stock, Retired, Par Value Method, Amount USD 0 2017-07-01 2018-06-30 2019 FY 10-K 2019-09-27 0000862668-19-000010
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 136,101 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-28 0000862668-18-000014
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 120,848 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap UnsecuredDebt Unsecured Debt USD 500,000 2020-12-31 2021 Q2 10-Q 2021-02-16 0000862668-21-000004
us-gaap UnsecuredDebtCurrent Unsecured Debt, Current USD 304,664 2020-09-30 2021 Q1 10-Q 2020-11-16 0000862668-20-000013
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -1.68M 2025-07-01 2026-06-30 2026 FY 10-K 2026-10-13 0001628280-26-065683
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 118,000 2022-07-01 2023-06-30 2023 FY 10-K 2023-10-13 0000862668-23-000022
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2014-06-30 2014 FY 10-K 2014-09-26 0000862668-14-000007
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0000862668-18-000025
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 14.19M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 7.42M 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000862668-24-000030
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 7.42M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001628280-26-074248

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →